SPECIAL EMPHASIS PANELS
To view other meetings from ZCA1 choose calendar year:
Study Section | Panel Name | Meeting Rosters |
---|---|---|
ZCA1 TCRB-V(O1) | CANCER MOONSHOT SCHOLARS DIVERSITY PROGRAM | 05/29/24 |
ZCA1 SRB-F(O2) | SEP-1: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/23/24 |
ZCA1 RTRB-R(O1) | NCI TRANSITION CAREER DEVELOPMENT AND INSTITUTIONAL RESEARCH TRAINING | 05/23/24 |
ZCA1 RPRB-L(O1) | SEP-11: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/23/24 |
ZCA1 TCRB-O(O1) | SEP-13: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/22/24 |
ZCA1 SRB-A(O1) | SEP-4: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/21/24 |
ZCA1 SRB-X(O1) | SEP-7: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/17/24 |
ZCA1 RPRB-8(O1) | NCI SPORE (P50) REVIEW SEP-I | 05/16/24 |
ZCA1 SRB-F(O1) | DIET, LIPID METABOLISM, AND CANCER | 05/16/24 |
ZCA1 SRB-2(A1) | COMPREHENSIVE PARTNERSHIPS TO ADVANCE CANCER HEALTH EQUITY (CPACHE, U54) | 05/16/24 |
ZCA1 SRB-E(O1) | SEP-10: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 05/15/24 |
ZCA1 RPRB-6(O1) | NCI SPORE (P50) REVIEW SEP-II | 05/15/24 |
ZCA1 TCRB-D(C1) | EPIDEMIOLOGY AND PREVENTION OF INFECTIONS AND RELATED DISEASES | 04/04/24 |
ZCA1 SRB-P(M2) | MECHANISMS OF FUSION-DRIVEN ONCOGENESIS IN CHILDHOOD CANCERS AND NEXT GENERATION CHEMISTRY CENTERS FOR FUSION ONCOPROTEINS | 03/27/24 |
ZCA1 RTRB-U(M3) | PRE-CANCER ATLAS RESEARCH CENTERS (RFA-CA-23-040) AND HUMAN TUMOR ATLAS NETWORK DATA COORDINATING CENTER (RFA-CA-23-041) | 03/21/24 |
ZCA1 SRB-2(M3) | SEP-2: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/21/24 |
ZCA1 RPRB-J(M2) | UTILIZING THE PLCO BIOSPECIMENS RESOURCE (U01) | 03/21/24 |
ZCA1 RPRB-L(M2) | AIDS AND CANCER SPECIMEN RESOURCE-UM1 | 03/20/24 |
ZCA1 RPRB-T(M2) | NCI SEP: HEALTH DISPARITIES IN UNDERREPRESENTED PEOPLE LIVING WITH HIV AND CANCER | 03/14/24 |
ZCA1 RTRB-F(M1) | ADVANCING CANCER CONTROL EQUITY RESEARCH (U19) | 03/13/24 |
ZCA1 RPRB-M(M2) | NCI RESEARCH PROJECT-COOPERATIVE AGREEMENTS (U01) | 03/13/24 |
ZCA1 TCRB-9(M1) | EARLY-STAGE DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT (U01 CLINICAL TRIAL OPTIONAL) | 03/13/24 |
ZCA1 RPRB-H(M2) | THE ROLE OF EPSTEIN BARR VIRUS (EBV) INFECTION IN NON-HODGKIN LYMPHOMA (NHL) AND HODGKIN DISEASE (HD) DEVELOPMENT WITH OR WITHOUT AN UNDERLYING HIV INFECTION | 03/13/24 |
ZCA1 SRB-A(M2) | TRANSLATIONAL RESEARCH TOWARD DEVELOPMENT OF A KAPOSI SARCOMA HERPESVIRUS (KSHV) VACCINE (U01) | 03/12/24 |
ZCA1 SRB-X(M3) | NCI PEDIATRIC EARLY PHASE CLINICAL TRIAL NETWORK | 03/07/24 |
ZCA1 RTRB-U(M2) | SEP-11: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/07/24 |
ZCA1 RTRB-B(M1) | SEP 11: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/07/24 |
ZCA1 TCRB-5(M1) | NCI INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH | 03/07/24 |
ZCA1 SRB-5(M1) | SEP-9: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/06/24 |
ZCA1 TCRB-J(M3) | ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH | 03/06/24 |
ZCA1 PCRB-E(M1) | R13 CONFERENCE GRANT REVIEW | 03/06/24 |
ZCA1 SRB-P(M1) | SEP-6: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 03/01/24 |
ZCA1 TCRB-9(C2) | TEP-6B: SBIR CONTRACT REVIEW | 03/01/24 |
ZCA1 SRB-K(M2) | HUMAN TUMOR ATLAS (HTA) RESEARCH CENTERS (U01) | 02/29/24 |
ZCA1 SRB-1(M2) | NCI RESEARCH SPECIALIST AWARD (R50) | 02/29/24 |
ZCA1 RPRB-8(M2) | NCI ASSAY VALIDATION OF HIGH QUALITY MARKERS FOR CLINICAL STUDIES IN CANCER (UH2/3) MEETING | 02/29/24 |
ZCA1 TCRB-J(C1) | TEP-4: SBIR CONTRACT REVIEW: MICROBIOME-BASED TESTS FOR CANCER RESEARCH | 02/29/24 |
ZCA1 RTRB-Z(M1) | SEP-8: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/29/24 |
ZCA1 TCRB-Q(C2) | TEP-3: SBIR CONTRACT REVIEW | 02/29/24 |
ZCA1 RPRB-N(M1) | NCI SPORE (P50) REVIEW SEP-IV | 02/28/24 |
ZCA1 TCRB-V(C2) | TEP-9: SBIR CONTRACT REVIEW | 02/28/24 |
ZCA1 RPRB-L(M1) | NCI PROGRAM PROJECT (P01) REVIEW SEP- C | 02/22/24 |
ZCA1 TCRB-9(C1) | TEP-6A: SBIR CONTRACT REVIEW | 02/22/24 |
ZCA1 SRB-1(M1) | NCI RESEARCH SPECIALIST AWARD (R50) CLINICIAN | 02/22/24 |
ZCA1 RTRB-S(M2) | SEP-10: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/22/24 |
ZCA1 SRB-8(M1) | SEP-3: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/21/24 |
ZCA1 RPRB-J(M1) | NCI PROGRAM PROJECT (P01) REVIEW SEP-A | 02/21/24 |
ZCA1 SRB-2(M2) | SEP-1: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/20/24 |
ZCA1 SRB-X(M2) | SEP-7: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/16/24 |
ZCA1 RPRB-6(M2) | NCI R01/R34 ADVANCING ADOLESCENT TOBACCO CESSATION INTERVENTION | 02/16/24 |
ZCA1 RPRB-M(M1) | NCI SPORE (P50) REVIEW SEP-III | 02/15/24 |
ZCA1 TCRB-5(C1) | TEP-7: SBIR CONTRACT REVIEW MEETING | 02/15/24 |
ZCA1 RPRB-8(M1) | NCI SPORE (P50) REVIEW SEP-I | 02/15/24 |
ZCA1 SRB-E(M1) | NCI OUTSTANDING INVESTIGATOR AWARD (R35) | 02/15/24 |
ZCA1 TCRB-Q(C1) | TEP-2: SBIR CONTRACT REVIEW | 02/15/24 |
ZCA1 RTRB-U(M1) | THE NCI PREDOCTORAL TO POSTDOCTORAL FELLOW TRANSITION AWARD (F99/K00) | 02/14/24 |
ZCA1 TCRB-9(C3) | TEP-8: SBIR CONTRACT REVIEW | 02/14/24 |
ZCA1 SRB-F(M1) | NCI PROGRAM PROJECT (P01) REVIEW SEP-D | 02/14/24 |
ZCA1 TCRB-Q(M1) | CANCER TECHNOLOGIES FOR GLOBAL HEALTH | 02/13/24 |
ZCA1 TCRB-V(C1) | TEP-5: SBIR CONTRACT REVIEW | 02/09/24 |
ZCA1 SRB-A(M1) | SEP-4: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/06/24 |
ZCA1 RPRB-T(M1) | NCI PROGRAM PROJECT (P01) REVIEW SEP - B | 02/06/24 |
ZCA1 RPRB-H(M1) | NCI SPORE (P50) REVIEW SEP-V | 02/06/24 |
ZCA1 SRB-K(M1) | SEP-5: NCI CLINICAL AND TRANSLATIONAL CANCER RESEARCH | 02/06/24 |
ZCA1 SRB-X(M1) | PROJECTS IN PHYSICAL SCIENCES ONCOLOGY REVIEW | 02/02/24 |
ZCA1 RTRB-S(M1) | METASTASIS RESEARCH NETWORK (U01) | 02/01/24 |
ZCA1 RPRB-6(M1) | NCI SPORE (P50) REVIEW SEP-II | 02/01/24 |
ZCA1 TCRB-O(C1) | TEP-1: SBIR CONTRACT REVIEW | 02/01/24 |
ZCA1 SRB-F(M2) | DIET, LIPID METABOLISM, AND TUMOR GROWTH AND PROGRESSION | 02/01/24 |
ZCA1 RTRB-R(M1) | NCI TRANSITION CAREER DEVELOPMENT AWARD AND INSTITUTIONAL RESEARCH TRAINING AND EDUCATION GRANTS | 01/25/24 |
ZCA1 TCRB-D(M2) | TECHNOLOGIES FOR CANCER RESEARCH | 01/25/24 |
ZCA1 TCRB-V(M1) | CLINICAL TRIALS PLANNING PROGRAM | 01/23/24 |
ZCA1 SRB-2(M1) | SURVIVORSHIP NEEDS OF INDIVIDUALS LIVING WITH ADVANCED CANCER (R01) | 01/11/24 |
ZCA1 TCRB-J(M1) | IMAT BIOSPECIMEN RESEARCH | 01/11/24 |
ZCA1 TCRB-J(M2) | INTEGRATING BIOSPECIMEN SCIENCE APPROACHES | 01/08/24 |